Blood markers may reveal breast Cancer's next move

NCT ID NCT07297134

Recruiting now Knowledge-focused Sponsor: Atlas University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether certain substances in the blood can help predict where breast cancer might spread. Researchers will measure levels of a protein called PTEN and specific microRNAs in blood samples from 160 women: 80 with metastatic breast cancer, 40 with early-stage breast cancer, and 40 healthy volunteers. The goal is to develop a non-invasive blood test that could guide doctors in monitoring and treating breast cancer more effectively.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple blood test that helps doctors predict where breast cancer might spread, enabling more personalized monitoring and treatment planning.
What could go wrong: This is an early observational study, not a treatment trial. The findings may not translate into a reliable clinical test, and the biomarkers identified may not be specific or sensitive enough for routine use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER METASTATIC BREAST CANCER MIRNAS PTEN

Contacts and locations

Locations

Atlas University Faculty of Medicine
RECRUITING

Istanbul, Istanbul, 34403, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.